Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
PRNewswire - October 29, 2009
The global infectious disease program, called RESPOND, funded at up to $185 million, is the largest of five U.S. Agency for International Development (USAID) projects designed to improve local institutional capacity to respond to "zoonotic" diseases--those that originate in animals and develop the capacity to infect humans.
"Even a partial list of recent zoonotic diseases--SARS, West Nile Virus, Ebola, avian influenza, novel H1N1--reveals the urgency of our work at the intersection of human and animal health," said Jerry Martin, Managing Director of DAI's Health Sector. "We're honored to implement this critically important program and excited to play a leadership role in responding to the next pandemic threat."
DAI leads a distinguished RESPOND team including the University of Minnesota, Tufts University, Training Resources Group, Inc., and Ecology and Environment, Inc.
This multidisciplinary team will build the capacity of national institutions of animal and public health to address emerging zoonotic diseases in designated "hot spot" regions. The project will be based in Washington, D.C., with possible field work implemented in regional hub offices across the Congo Basin, Southeast Asia, the Amazon Basin, and the Gangetic Plain.
Combining animal and human health epidemiology and disease surveillance, RESPOND will employ an integrated approach that unites physicians, public health officials, veterinarians, and the private sector to combat emerging disease on a global scale. The program will focus on long-term field epidemiology training, short-term in-service training, and academic preparation for health professionals. The program will also seek to identify and counter outbreaks while they are still within animal populations, as well as strengthen the capacity to respond to outbreaks within human communities.
RESPOND will be led by DAI's David Elkins, an epidemiologist and public health specialist with 25 years of field experience, including 20 years in Southeast Asia, the Gangetic Plain, and East Africa. Dr. Elkins has led numerous projects for international development organizations.
DAI is a recognized leader in the zoonotic disease arena. The firm currently manages two major USAID projects to control and prevent highly pathogenic avian influenza (HPAI): the worldwide Stamping Out Pandemic and Avian Influenza (STOP AI) and the Indonesia Community-Based Avian Influenza Control (CBAIC) programs, which train animal and public health workers, mobilize communities for disease surveillance and reporting, support HPAI outbreak response, and facilitate private sector partnerships to limit virus transmission in domestic animal production systems.
About DAI
DAI works at the cutting edge of international development, combining technical excellence, professional project management, and exceptional customer service to solve our clients' most complex problems. Since 1970, DAI has worked in 150 developing and transition countries, providing comprehensive development solutions in areas including HIV/AIDS and avian influenza control, crisis mitigation and stability operations, agriculture and agribusiness, democratic governance and public sector management, private sector development and financial services, economics and trade, water and natural resources management, and energy and climate change.
DAI's Health Sector harnesses the skills of public and animal health specialists, private sector development experts, microfinance practitioners, water resource managers, communications professionals, governance experts, and our agriculture and agribusiness staff to address current and emerging health threats. In marshalling these resources, DAI is taking a leadership role at the crucial intersection where human health, animal health, and economic development come together.
Source: DAI
CONTACT: Steven O'Connor, Director of Communications of DAI, +1-301-771-7834, Steven_O'Connor@dai.com
Web Site: http://www.dai.com/
091029
PR091039
Copyright © 2009 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .